Every year, throughout the month of October, we honor Max and his legacy by partnering with our network of cancer organizations to carry out the Maximize Life Global Cancer Awareness Campaign. It is a month of service that aims at decreasing stigma and increasing hope for people living with cancer around the world.
It is Max’s story that originally inspired the birth of the organization. It is all of the cancer survivors, advocates, and patient leaders around the world that continue to inspire us today. In this way, our past and our future are interconnected.
As a very special tribute, we bring two friends and colleagues together to talk about Max the person. Pat, our CEO and Max’s step-mom was interviewed by advocate, cancer survivor and team member, Fan. Their bond, their friendship, their mutual respect and their shared mission are all revealed through an intimate conversation.
Listen to Pat reflect on Max’s story and legacy.
To bring light to this powerful shared story, we availed an exciting new storytelling platform created by the non-profit organization called StoryCorps. By using StoryCorp technology, this meaningful journey is documented for posterity, as well as for sharing easily with all of you. We are looking forward to using StoryCorps for future storytelling opportunities.
We invite your thoughts and comments below in recognition of October 19th. In honor of Max and in partnership with all of you, we thank you for listening.
The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 28 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.
Cancerworld recently published an article by Ann Wagstaff titled Begging for imatinib: why do so many patients still lack access to this lifesaver? It highlights the challenges people living with CML face in accessing imatinib, a life-extending medicine that has been generic for many years. Here is our perspective on the story. We have known….
Join us this summer in Malaysia! In July 2017, a team of partners, cancer survivors, and friends like you will join us from the USA, Malaysia, and beyond to embark on an adventure with a common goal: raising funds to carry out our work supporting cancer patients in Malaysia.
Thousands of patients are diagnosed with chronic myeloid leukaemia (CML) annually around the world. CML, like any other cancer, does not discriminate. It affects people from all regions and walks of life. However, unlike many other cancers, CML has an amazing story due to advancements made in its treatment in the last decade. It was only 15 years ago that a patient newly diagnosed with CML would have a prognosis of survival of less than 5 years with the treatments available at the time.
